Mao Sheng Duan
Corporate Officer/Principal at HD Biosciences Co., Ltd.
Profile
Mao Sheng Duan is currently the Vice President & Head-Medicinal Chemistry at HD Biosciences Co., Ltd.
Prior to this, he worked as the Chief Scientist at Glaxosmithkline China Ltd.
Dr. Duan received his doctorate degree from The Ohio State University and his undergraduate and graduate degrees from Central China Normal University and Nankai University respectively.
Mao Sheng Duan active positions
| Companies | Position | Start |
|---|---|---|
HD Biosciences Co., Ltd.
 HD Biosciences Co., Ltd. Medical/Nursing ServicesHealth Services HD Biosciences Co., Ltd. operates as a biotech company. It specializes in drug discovery contract research. The company offers comprehensive technology platforms and expertise services around hit to lead and lead optimization in preclinical drug discovery and development, which includes biology assays and assay development, compound profiling, high throughput screening, DMPK, in vivo pharmacology, drug efficacy and safety, as well as natural product based lead compound discovery. The company was founded in October 2002 and is headquartered in Shanghai, China. | Corporate Officer/Principal | - |
Former positions of Mao Sheng Duan
| Companies | Position | End |
|---|---|---|
| Glaxosmithkline China Ltd. | Corporate Officer/Principal | - |
Training of Mao Sheng Duan
| The Ohio State University | Graduate Degree |
| Nankai University | Graduate Degree |
| Central China Normal University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
HD Biosciences Co., Ltd.
HD Biosciences Co., Ltd. Medical/Nursing ServicesHealth Services HD Biosciences Co., Ltd. operates as a biotech company. It specializes in drug discovery contract research. The company offers comprehensive technology platforms and expertise services around hit to lead and lead optimization in preclinical drug discovery and development, which includes biology assays and assay development, compound profiling, high throughput screening, DMPK, in vivo pharmacology, drug efficacy and safety, as well as natural product based lead compound discovery. The company was founded in October 2002 and is headquartered in Shanghai, China. | Health Services |
| Glaxosmithkline China Ltd. |
- Stock Market
- Insiders
- Mao Sheng Duan
